2014 Speakers

  • Recommend
  • Tweet
  • Print
  • Email

Below is a list of the 2014 BIO CEO & Investor Conference speakers.

 

 

Photo Name and Title Panel, Date, Time Location
Andy Acker Andrew Acker, CFA
Portfolio Manager
Janus Global Life Sciences
 
Opening Plenary: A Room with a (Buy-Side) View: The Year Ahead
Monday, February 10, 2014
12:00 p.m. - 12:55 p.m.
Astor
Christopher Anzalone, PhD 
President and CEO
​Arrowhead Research Corporation
Solution Development: Aiming the Whole Pipeline at a Single Goal
Monday, February 10, 2014
9:00 a.m. - 9:55 a.m.
Jade
Peter Bach, MD, MAPP
Attending Physician
Memorial Sloan-Kettering Cancer Center
The Reimbursement Landscape Under ACA
Tuesday, February 11, 2014
12:00 p.m. - 12:55 p.m.
Jade
Liisa A. Bayko
Managing Director, Senior Analyst, Biotechnology
JMP Securities
Balancing the Risk-Reward in Rare Disease Drug Development 
Monday, February 10, 2014
2:00 p.m. - 2:55 p.m.
Jade
Leonard Bell, MD
Chief Executive Officer
Alexion Pharmaceuticals
Fireside Chat
Tuesday, February 11, 2014 
11:00 a.m.
Astor
Seng H. Cheng, PhD
Head of Research & Early Development, Rare Diseases Division
Genzyme
Balancing the Risk-Reward in Rare Disease Drug Development 
Monday, February 10, 2014
2:00 p.m. - 2:55 p.m.
Jade
Dr. Tim Coté Timothy R. Coté, MD, MPH
Principal & CEO
Coté Orphan Consulting
Balancing the Risk-Reward in Rare Disease Drug Development 
Monday, February 10, 2014
2:00 p.m. - 2:55 p.m.
Jade
Milind S. Deshpande, PhD
President & CEO
Achillion Pharmaceuticals
Solution Development: Aiming the Whole Pipeline at a Single Goal
Monday, February 10, 2014
9:00 a.m. - 9:55 a.m.
Jade
Andrew Dickerson Fireside Chat (Moderator)
Tuesday, February 11, 2014 
12:00 p.m.
Astor
Michael Diem
Global Vice President & Head of Corporate Strategy
AstraZeneca
Let's Make a Deal — Strategic Licensing and M&A Trends
Tuesday, February 11, 2014
9:00 a.m. - 9:55 a.m.
Jade
Michelle Dipp, MD, PhD
CEO & Co-Founder
OvaScience
Let's Make a Deal — Strategic Licensing and M&A Trends
Tuesday, February 11, 2014
9:00 a.m. - 9:55 a.m.
Jade
David H. Donabedian, PhD
Vice President, Head of Venture Investments & Early Stage Collaborations
AbbVie
Let's Make a Deal — Strategic Licensing and M&A Trends
Tuesday, February 11, 2014
9:00 a.m. - 9:55 a.m.
Jade
Stanley C. Erck
President & CEO
Novavax
Solution Development: Aiming the Whole Pipeline at a Single Goal
Monday, February 10, 2014
9:00 a.m. - 9:55 a.m.
Jade
Douglas Fambrough, PhD
CEO
Dicerna Pharmaceuticals
Delivering the [RNAi] Goods
Monday, February 10, 2014 
10:30 a.m. - 11:25 a.m.
Jade
Seamus Fernandez
Managing Director, Major and Specialty Pharmaceuticals
Leerink Partners LLC
Fireside Chat (Moderator)
Tuesday, February 11, 2014 
8:00 a.m.
Astor
Belén Garijo, M.D.
President and CEO
Merck Serono
Fireside Chat
Tuesday, February 11, 2014 
12:00 p.m.
Astor
Anthony J. Gibney
Managing Director
Leerink Partners LLC
Fireside Chat (Moderator)
Monday, February 10, 2014 
3:30 p.m.
Astor
Bruce Given, MD
Chief Operating Officer
Arrowhead Research Corporation
Delivering the [RNAi] Goods
Monday, February 10, 2014
10:30 a.m. - 11:25 a.m.
Jade
David Gluckman, MD
Managing Director, Global Co-Head of Healthcare
Lazard
Fireside Chat (Moderator)
Monday, February 10, 2014 
8:00 a.m.
Astor
Kurt Graves
Chairman, President & CEO
Intarcia Therapeutics
Solution Development: Aiming the Whole Pipeline at a Single Goal
Monday, February 10, 2014
9:00 a.m. - 9:55 a.m.
Jade
David-Alexandre Gros David-Alexandre Gros, MD
Executive Vice President, Chief Strategy Officer
Sanofi
Closing Plenary: Fundraising in the New Capital Market Environment
Tuesday, February 11, 2014
4:00 p.m. – 4:55 p.m.
Astor
Annalisa Jenkins, MBBS, MRCP
Executive VP & Head of Global Research and Development
Merck KGaA
Keeping an I on Oncology: The ASCO Immunotherapy Preview
Tuesday, February 11, 2014 
1:30 p.m. – 2:25 p.m.
Jade
Michael G. King, Jr.
Senior Analyst, Biotechnology
JMP Securities
Keeping an I on Oncology: The ASCO Immunotherapy Preview
Tuesday, February 11, 2014 
1:30 p.m. – 2:25 p.m.
Jade
Rachel K. King
CEO
GlycoMimetics
 
The Reimbursement Landscape Under ACA
Tuesday, February 11, 2014
12:00 p.m. - 12:55 p.m.
Jade
J.D. Kleinke
Healthcare Business Strategist
The Reimbursement Landscape Under ACA
Tuesday, February 11, 2014
12:00 p.m. - 12:55 p.m.
Jade
Peter Kolchinsky, PhD
Managing Director
RA Capital Management, LLC
Solution Development: Aiming the Whole Pipeline at a Single Goal
Monday, February 10, 2014
9:00 a.m. - 9:55 a.m.
Jade
Adam Koppel, MD, PhD
Managing Director
Brookside Capital Partners Fund, LP
Opening Plenary: A Room with a (Buy-Side) View: The Year Ahead
Monday, February 10, 2014
12:00 p.m. - 12:55 p.m.
Astor
Jonathan L. Kravetz
Chair of the Securities Practice Group
Mintz Levin
Closing Plenary: Fundraising in the New Capital Market Environment
Tuesday, February 11, 2014
4:00 p.m. – 4:55 p.m.
Astor
Roger Longman
Chief Executive Officer
Real Endpoints
The Reimbursement Landscape Under ACA
Tuesday, February 11, 2014
12:00 p.m. - 12:55 p.m.
Jade
Barry Greene
President & Chief Operating Officer
Alnylam Pharmaceuticals
Delivering the [RNAi] Goods
Monday, February 10, 2014 
10:30 a.m. - 11:25 a.m.
Jade
Michael Margolis, R.Ph.
Managing Director
ROTH Capital Partners
Closing Plenary: Fundraising in the New Capital Market Environment
Tuesday, February 11, 2014
4:00 p.m. – 4:55 p.m.
Astor
Ed Mathers
Partner
New Enterprise Associates
Closing Plenary: Fundraising in the New Capital Market Environment
Tuesday, February 11, 2014
4:00 p.m. – 4:55 p.m.
Astor
Oleg Nodelman
Founder and Managing Director
EcoR1 Capital
Opening Plenary: A Room with a (Buy-Side) View: The Year Ahead
Monday, February 10, 2014
12:00 p.m. - 12:55 p.m.
Astor
Richard F. Pops
Chairman & Chief Executive Officer
Alkermes plc
Fireside Chat 
Monday, February 10, 2014 
8:00 a.m.
 
Astor
Dennis Purcell
Senior Managing Partner
Aisling Capital
Closing Plenary: Fundraising in the New Capital Market Environment
Tuesday, February 11, 2014
4:00 p.m. – 4:55 p.m.
Astor
David E.I. Pyott
Chairman of the Board & Chief Executive Officer
Allergan
Fireside Chat
Tuesday, February 11, 2014 
8:00 a.m.
Astor
Rajesh Ranganathan, PhD
Director, Translational Research
NIH/NINDS
Balancing the Risk-Reward in Rare Disease Drug Development 
Monday, February 10, 2014
2:00 p.m. - 2:55 p.m.
Jade
Hans GCP Schikan, PharmD
CEO
Prosensa
Balancing the Risk-Reward in Rare Disease Drug Development
Monday, February 10, 2014
2:00 p.m. - 2:55 p.m.
Jade
Eric Schmidt, PhD
Managing Director
Cowen Group
Fireside Chat (Moderator)
Tuesday, February 11, 2014 
11:00 a.m.
Astor
Mark Schoenebaum, MD
Senior Managing Director
ISI Group
Opening Plenary: A Room with a (Buy-Side) View: The Year Ahead
Monday, February 10, 2014
12:00 p.m. - 12:55 p.m.
Astor
William S. Slattery
Partner
Deerfield Management Company
Opening Plenary: A Room with a (Buy-Side) View: The Year Ahead
Monday, February 10, 2014
12:00 p.m. - 12:55 p.m.
Astor
Melinda Thiel
Vice President, Pharmacy
HealthFirst
The Reimbursement Landscape Under ACA
Tuesday, February 11, 2014
12:00 p.m. - 12:55 p.m.
Jade
Laurel Todd
Managing Director, Reimbursement & Health Policy
BIO
The Reimbursement Landscape Under ACA
Tuesday, February 11, 2014
12:00 p.m. - 12:55 p.m.
Jade
Effie Toshav
Partner
Fenwick & West LLP
Let's Make a Deal — Strategic Licensing and M&A Trends
Tuesday, February 11, 2014
9:00 a.m. - 9:55 a.m.
Jade
Peter G. Traber, MD
President, CEO & CMO
Galectin Therapeutics
Keeping an I on Oncology: The ASCO Immunotherapy Preview
Tuesday, February 11, 2014 
1:30 p.m. – 2:25 p.m.
Jade
Christopher A. Viehbacher
Chief Executive Officer
Sanofi
Chairman, Genzyme
President of the EFPIA, European Federation of Pharmaceutical Industries and Associations
Fireside Chat
Monday, February 10, 2014 
3:30 p.m.
Astor
Samuel D. Waksal, PhD
Chairman & CEO
Kadmon Corporation
Keeping an I on Oncology: The ASCO Immunotherapy Preview
Tuesday, February 11, 2014 
1:30 p.m. – 2:25 p.m.
Jade
Jeffrey S. Weber, MD, PhD,
Senior Member, H Lee Moffitt Cancer Center
Director, Donald A. Adam Comprehensive Melanoma Research Center
Keeping an I on Oncology: The ASCO Immunotherapy Preview
Tuesday, February 11, 2014 
1:30 p.m. – 2:25 p.m.
Jade
Thomas Wei
Senior Research Analyst, Biotechnology
Jefferies LLC
Delivering the [RNAi] Goods
Monday, February 10, 2014 
10:30 a.m. - 11:25 a.m.
Jade
Jon Wigginton, MD
Senior Vice President, Clinical Research
MacroGenics
Keeping an I on Oncology: The ASCO Immunotherapy Preview
Tuesday, February 11, 2014 
1:30 p.m. – 2:25 p.m.
Jade
Kleanthis G. Xanthopoulos, PhD
President & CEO
Regulus Therapeutics
Delivering the [RNAi] Goods
Monday, February 10, 2014 
10:30 a.m. - 11:25 a.m.
Jade